Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.

Baptista T, Rangel N, Fernández V, Carrizo E, El Fakih Y, Uzcátegui E, Galeazzi T, Gutiérrez MA, Servigna M, Dávila A, Uzcátegui M, Serrano A, Connell L, Beaulieu S, de Baptista EA.

Schizophr Res. 2007 Jul;93(1-3):99-108. Epub 2007 May 8.

PMID:
17490862
[PubMed - indexed for MEDLINE]
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
3.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
4.

Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.

Praharaj SK, Jana AK, Goyal N, Sinha VK.

Br J Clin Pharmacol. 2011 Mar;71(3):377-82. doi: 10.1111/j.1365-2125.2010.03783.x. Review.

PMID:
21284696
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials.

Pappadopulos E, Newcomer JW, Kolluri S.

J Clin Psychiatry. 2012 Jun;73(6):e742-8. doi: 10.4088/JCP.10r06802. Review.

PMID:
22795213
[PubMed - indexed for MEDLINE]
6.

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.

Bushe CJ, Bradley AJ, Doshi S, Karagianis J.

Int J Clin Pract. 2009 Dec;63(12):1743-61. doi: 10.1111/j.1742-1241.2009.02224.x. Epub 2009 Oct 19. Review.

PMID:
19840151
[PubMed - indexed for MEDLINE]
7.

The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.

Khan AY, Macaluso M, McHale RJ, Dahmen MM, Girrens K, Ali F.

J Psychiatr Pract. 2010 Sep;16(5):289-96. doi: 10.1097/01.pra.0000388624.91039.a3. Review.

PMID:
20859106
[PubMed - indexed for MEDLINE]
8.

Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.

Sentissi O, Epelbaum J, Olié JP, Poirier MF.

Schizophr Bull. 2008 Nov;34(6):1189-99. doi: 10.1093/schbul/sbm141. Epub 2007 Dec 28. Review.

PMID:
18165262
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.

Björkhem-Bergman L, Asplund AB, Lindh JD.

J Psychopharmacol. 2011 Mar;25(3):299-305. doi: 10.1177/0269881109353461. Epub 2010 Jan 15. Review.

PMID:
20080925
[PubMed - indexed for MEDLINE]
10.

A systematic review of metformin to limit weight-gain with atypical antipsychotics.

Lee YJ, Jeong JH.

J Clin Pharm Ther. 2011 Oct;36(5):537-45. doi: 10.1111/j.1365-2710.2011.01255.x. Epub 2011 Mar 21. Review.

PMID:
21418264
[PubMed - indexed for MEDLINE]
11.

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Maayan L, Vakhrusheva J, Correll CU.

Neuropsychopharmacology. 2010 Jun;35(7):1520-30. doi: 10.1038/npp.2010.21. Epub 2010 Mar 24. Review.

PMID:
20336059
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk